We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Launches First Price Gouging Investigation into Aspen Pharma
EC Launches First Price Gouging Investigation into Aspen Pharma
The European Commission has opened a formal antitrust investigation into South African manufacturer Aspen Pharma over concerns of excessive pricing of five cancer medicines.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor